1594129-41-5

Upstream product

• 1594130-93-4 ((S)-1-(4-(((R)-1-(4-hydroxyphenyl)pyrrolidin-3-yl)oxy)phenyl)ethyl)acetamide 
• 100-39-0 benzyl bromide 
• 186296-23-1 (S)-N-(1-(4-bromophenyl)ethyl)acetamide 
• 27298-97-1 (S)-1-(4-bromophenyl)ethylamine 
• 1594129-62-0 (R)-tert-butyl 3-(4-((S)-1-acetamidoethyl)phenoxy)pyrrolidine-1-carboxylate 
• 1443670-29-8 (S)-N-(1-(4-hydroxyphenyl)ethyl)acetamide 
• 6793-92-6 p-benzyloxyphenylbromide 
• 1594129-68-6 N-((S)-1-(4-((R)-pyrrolidin-3-yloxy)phenyl)ethyl)acetamide hydrochloride 

Downstream Products

• 1594130-93-4 ((S)-1-(4-(((R)-1-(4-hydroxyphenyl)pyrrolidin-3-yl)oxy)phenyl)ethyl)acetamide 
• 1594129-37-9 N-((S)-1-(4-((R)-1-(4-(3-methoxypropoxy)phenyl)pyrrolidin-3-yloxy)phenyl)ethyl)-acetamide 

Relevant academic research and scientific papers

NEW PYRROLIDINE DERIVATIVES AND THEIR USE AS ACETYL-COA CARBOXYLASE INHIBITORS

The invention relates to new pyrrolidine derivatives of the formula (I) to their use as medicaments, to methods for their therapeutic use and to pharmaceutical compositions containing them.

New pyrrolidine derivatives, pharmaceutical compositions and uses thereof

Pyrrolidine derivatives of the formula and their use as medicaments for the treatment of obesity and type 2 diabetes.